CBD Products - EMEA

EMEA

Revenue in the EMEA region's CBD Products market is forecasted to reach US$2.40bn in 2024.
The revenue is anticipated to demonstrate an annual growth rate (CAGR 2024-2029) of 0.66%, leading to a market volume of US$2.48bn by 2029.
When compared globally, the United States is expected to generate the highest revenue (US$2,575.00m in 2024).
In terms of per person revenues in 2024, US$22.67 is generated concerning total population figures.
The EMEA region is experiencing a surge in demand for CBD derivatives in the cannabis market, driven by evolving regulations and increasing consumer awareness.

Key regions: Netherlands, Spain, United States, Europe, Australia

Market

Region

Region comparison

Currency

Analyst Opinion

The CBD Products market in EMEA is experiencing significant growth and development, driven by various factors influencing consumer preferences and market trends.

Customer preferences: Consumers in EMEA are increasingly turning to CBD products due to growing awareness of their potential health benefits and therapeutic properties. Many individuals are seeking natural alternatives for wellness and skincare, leading to a rise in demand for CBD-infused products. Additionally, there is a shift towards sustainable and eco-friendly options, with customers showing a preference for ethically sourced and organic CBD products.

Trends in the market: In the United Kingdom, there has been a notable trend towards CBD oils and tinctures, with a focus on high-quality and premium formulations. The market is also seeing a surge in CBD-infused beauty and skincare products, catering to the rising demand for natural and organic cosmetics. Furthermore, the increasing popularity of CBD edibles and beverages is shaping the market landscape, with innovative product offerings entering the market.

Local special circumstances: In Germany, the CBD market is influenced by strict regulations and quality standards, impacting product availability and pricing. The country has seen a growing interest in pharmaceutical-grade CBD products, particularly for medicinal purposes. Additionally, the wellness and fitness industry in Germany is driving the demand for CBD supplements and topicals, creating opportunities for market expansion.

Underlying macroeconomic factors: The economic stability and disposable income levels in EMEA countries play a significant role in shaping the CBD Products market. As consumer spending power increases, there is a greater willingness to invest in premium CBD products and explore new product categories. Moreover, regulatory frameworks and government policies regarding CBD legalization and product safety standards impact market growth and consumer trust in the region.

Methodology

Data coverage:

Data encompasses B2B and B2C enterprises. Figures are based on companies' revenues, funding values and global consumer survey data. Revenues include retail, sales and taxes.

Modeling approach / Market size:

Market sizes are determined by a Top-Down approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports, third-party data. Next, we use relevant key market indicators and data from country-specific associations such as tobacco spending per capita, medical product spending per capita, consumer spending and consumer spending for recreation purposes, population. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.